Related references
Note: Only part of the references are listed.A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis
Merja Soilu-Hanninen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial
Margitta T. Kampman et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial
Jan Doerr et al.
TRIALS (2012)
Rare variants in the CYP27B1 gene are associated with multiple sclerosis
Sreeram V. Ramagopalan et al.
ANNALS OF NEUROLOGY (2011)
Assessment of evidence for a protective role of vitamin D in multiple sclerosis
Heather E. C. Hanwell et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Why the IOM Recommendations for Vitamin D Are Deficient
Robert P. Heaney et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
A. Catharine Ross et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Vitamin D has a direct immunomodulatory effect on CD8+T cells of patients with early multiple sclerosis and healthy control subjects
Andreas P. Lysandropoulos et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Vitamin D in the healthy and inflamed central nervous system: access and function
Joost Smolders et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial
Joost Smolders et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Prevention and treatment of MS: studying the effects of vitamin D
Kassandra L. Munger et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Switching Multiple Sclerosis Patients with Breakthrough Disease to Second-Line Therapy
Tamara Castillo-Trivino et al.
PLOS ONE (2011)
Widespread vitamin D insufficiency: A new challenge for primary prevention, with particular reference to multiple sclerosis
Charles Pierrot-Deseilligny et al.
PRESSE MEDICALE (2011)
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice
Jean-Claude Souberbielle et al.
AUTOIMMUNITY REVIEWS (2010)
Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?
Charles Pierrot-Deseilligny et al.
BRAIN (2010)
Vitamin D: Evolutionary, Physiological and Health Perspectives
Michael F. Holick
CURRENT DRUG TARGETS (2010)
Gender Differences in 1,25 Dihydroxyvitamin D3 Immunomodulatory Effects in Multiple Sclerosis Patients and Healthy Subjects
Jorge Correale et al.
JOURNAL OF IMMUNOLOGY (2010)
Vitamin D Intake Needed to Maintain Target Serum 25-Hydroxyvitamin D Concentrations in Participants with Low Sun Exposure and Dark Skin Pigmentation Is Substantially Higher Than Current Recommendations
Laura M. Hall et al.
JOURNAL OF NUTRITION (2010)
Common genetic determinants of vitamin D insufficiency: a genome-wide association study
Thomas J. Wang et al.
LANCET (2010)
Vitamin D and multiple sclerosis
Alberto Ascherio et al.
LANCET NEUROLOGY (2010)
Immunomodulatory effects of vitamin D on monocyte-derived dendritic cells in multiple sclerosis
Halina Bartosik-Psujek et al.
MULTIPLE SCLEROSIS (2010)
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
J. M. Burton et al.
NEUROLOGY (2010)
Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: impact on the clinical cut offs
E. Cavalier et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Safety and T Cell Modulating Effects of High Dose Vitamin D3 Supplementation in Multiple Sclerosis
Joost Smolders et al.
PLOS ONE (2010)
Addressing vitamin D deficiency in Canada: A public health innovation whose time has come
G. K. Schwalfenberg et al.
PUBLIC HEALTH (2010)
Prevention of Nonvertebral Fractures With Oral Vitamin D and Dose Dependency A Meta-analysis of Randomized Controlled Trials
Heike A. Bischoff-Ferrari et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Immunomodulatory effects of Vitamin D in multiple sclerosis
Jorge Correale et al.
BRAIN (2009)
Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis
Walter Royal et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Clinical implications of a possible role of vitamin D in multiple sclerosis
Charles Pierrot-Deseilligny
JOURNAL OF NEUROLOGY (2009)
Vitamin D3 Distribution and Status in the Body
Robert P. Heaney et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2009)
Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosis
A. Gajofatto et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis
T. Hagenau et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Vitamin D Status Is Positively Correlated with Regulatory T Cell Function in Patients with Multiple Sclerosis
Joost Smolders et al.
PLOS ONE (2009)
Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients
Sophia Ish-Shalom et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Vitamin D as an immune modulator in multiple sclerosis, a review
Joost Smolders et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Environmental factors and multiple sclerosis
George C. Ebers
LANCET NEUROLOGY (2008)
Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis
J. Smolders et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Evaluation and correction of low vitamin D status
Neil Binkley et al.
Current Osteoporosis Reports (2008)
Vitamin D deficiency
Michael F. Holick
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
Alberto Ascherio et al.
ANNALS OF NEUROLOGY (2007)
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia
I. A. F. van der Mei et al.
JOURNAL OF NEUROLOGY (2007)
Novel insights in the immune function of the vitamin D system: Synergism with interferon-beta
Evelyne van Etten et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis
Kassandra L. Munger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
What is the optimal vitamin D status for health?
Reinhold Vieth
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis
DM Wingerchuk et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Twenty-four-month comparison of immunomodulatory treatments -: a retrospective open label study in 308 RRMS patients treated with beta interferons or glatiramer acetate (Copaxone®)
J Haas et al.
EUROPEAN JOURNAL OF NEUROLOGY (2005)
Cytokine profile in patients with multiple sclerosis following vitamin D supplementation
BD Mahon et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Share Paper
